AQST Aquestive Therapeutics, Inc. - Common Stock
NASDAQ · Pharmaceuticals · 在 SEC EDGAR 上查看 ↗ 收盘 十月 2, 2026 10-K/10-Q 八月 11, 2026
$4.55
· % 处于52周区间
· 高于低点
· 至高点
$3.1052周低点
$7.5552周高点
市值 (MRQ)
$571M
P/E (TTM)
-7.0
EPS (TTM)
$-0.65
收入 (TTM)
$54M
AQST 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$4.55
市值 (MRQ)
$571M
P/E (TTM)
-7.0
EPS (TTM)
$-0.65
收入 (TTM)
$54M
ROE (TTM)
121.1%
52周区间
$3–$8
AQST 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
区间
条形图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
10年表现 收入、净利润、利润率和每股收益趋势
收入$45M2017-12-31 → 2025-12-31
EPS$-0.782020-12-31 → 2025-12-31
自由现金流$-53M2018-12-31 → 2025-12-31
净利率-144.6%2018-12-31 → 2025-12-31
估值与比率
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | AQST | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E (TTM) | -7.05年均值 ≈-6.7 | ≈-6.7 | · | · | |
| P/S (TTM) | 10.65年均值 ≈6.1 | ≈6.1 | 2.7 | 估值过高 | |
| 市净率 (MRQ) | -10.15年均值 ≈-6.5 | ≈-6.5 | · | · | |
| 股价/自由现金流 (TTM) | -12.45年均值 ≈-10.4 | ≈-10.4 | · | · | |
| 市现率 (TTM) | -12.65年均值 ≈-11.2 | ≈-11.2 | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | AQST | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 营业利润率 (TTM) | -97.5%5年均值 ≈-79.9% | ≈-79.9% | -1.8% | 弱 | |
| EBITDA Margin (息税折旧摊销前利润率) | -159.5%5年均值 ≈-79.9% | ≈-79.9% | 1.8% | 弱 | |
| 税前利润率 (TTM) | -144.6%5年均值 ≈-106.5% | ≈-106.5% | -6.8% | 弱 | |
| 净利润率 (TTM) | -144.6%5年均值 ≈-106.6% | ≈-106.6% | -7.5% | 弱 | |
| ROA (TTM) | -69.3%5年均值 ≈-67.5% | ≈-67.5% | -15.7% | 弱 | |
| ROE (TTM) | 121.1%5年均值 ≈79.2% | ≈79.2% | 52.3% | 顶尖 | |
| ROIC | 211.1%5年均值 ≈70.9% | ≈70.9% | 40.3% | 顶尖 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | AQST | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 流动比率 (MRQ) | 7.25年均值 ≈2.6 | ≈2.6 | 3.0 | 流动性强 | |
| Quick Ratio (速动比率) | 0.4 | · | 2.0 | 流动性强 |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
| 指标 | 5年趋势 | AQST | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue YoY (营收同比增长) | -22.6%5年均值 ≈0.39% | ≈0.39% | · | · | |
| Revenue CAGR 3Y (营收3年复合年增长率) | -2.2%5年均值 ≈1.8% | ≈1.8% | · | · | |
| Revenue CAGR 5Y (营收5年复合年增长率) | -0.58% | · | · | · |
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | AQST | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Asset Turnover (资产周转率) | 0.35年均值 ≈0.7 | ≈0.7 | 0.5 | 弱 | |
| Inventory Turnover (库存周转率) | 3.05年均值 ≈3.0 | ≈3.0 | 3.0 | 持平 | |
| Receivables Turnover (应收账款周转率) | 3.5 | · | 3.5 | 弱 | |
| Revenue / Employee (年营业收入 ÷ 员工人数（报告的 headcount，yfinance）。衍生数据 — 非存储的 SEC-XBRL 概念。) | ≈$303.0K | · | · | · |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
6.6%
下次报告
十一月 03, 2026
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | 八月 11, 2026 | $-0.08 | $-0.11 | 24.1% |
| 2026年3月31日 | 五月 13, 2026 | $-0.07 | $-0.14 | 50.0% |
| 2025年12月31日 | $-0.15 | $-0.14 | -10.9% | |
| 2025年9月30日 | $-0.14 | $-0.14 | -3.6% | |
| 2025年6月30日 | $-0.14 | $-0.17 | 18.5% | |
| 2025年3月31日 | $-0.24 | $-0.17 | -38.4% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $45M | $58M | $51M | $48M | $51M | $46M | $53M | $67M | $67M | |
| Cost of Revenue | $19M | $18M | $21M | $19M | · | $13M | $20M | · | · | |
| R&D Expense | $17M | $20M | $13M | $17M | $17M | $20M | $21M | $23M | $22M | |
| SG&A Expense | $80M | $50M | $32M | $53M | $53M | $56M | $64M | $72M | $25M | |
| Operating Expenses | $116M | $88M | $66M | $90M | $86M | $89M | $105M | $116M | $67M | |
| Operating Income | $-71M | $-31M | $-15M | $-42M | $-35M | $-43M | $-53M | $-49M | $-113.0K | |
| Interest Expense | · | · | $6M | $7M | $10M | $11M | $9M | $8M | $8M | |
| Interest Income | · | · | · | · | · | $132.0K | $636.0K | · | · | |
| Pretax Income | $-84M | $-44M | $-8M | $-54M | $-71M | $-56M | $-66M | $-61M | $-9M | |
| Income Tax | $0 | $-14.0K | $245.0K | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-84M | $-44M | $-8M | $-54M | $-71M | $-56M | $-66M | $-61M | $-9M | |
| EPS (Basic) | $-0.78 | $-0.51 | $-0.13 | $-1.12 | $-1.85 | $-1.66 | · | · | · | |
| EPS (Diluted) | $-0.78 | $-0.51 | $-0.13 | $-1.12 | $-1.85 | $-1.66 | · | · | · | |
| Shares (Basic) | 106,926,528 | 86,726,211 | 61,255,864 | 48,734,377 | 38,077,660 | 33,651,127 | · | · | · | |
| Shares (Diluted) | 106,926,528 | 86,726,211 | 61,255,864 | 48,734,377 | 38,077,660 | 33,651,127 | · | · | · | |
| EBITDA | $-71M | $-31M | $-15M | $-42M | $-35M | $-43M | $-53M | $-46M | · |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $121M | $72M | $24M | $27M | $28M | $32M | $49M | $61M | $17M | |
| Receivables | $18M | $7M | $8M | · | · | · | · | · | $6M | |
| Inventory | $6M | $6M | $7M | $6M | $4M | $2M | $3M | $5M | $4M | |
| Prepaid Expense | $4M | $3M | $2M | $2M | $3M | $3M | $3M | $2M | $591.0K | |
| Current Assets | $149M | $88M | $41M | $40M | $47M | $45M | $68M | $74M | $28M | |
| PP&E (Net) | $4M | $4M | $4M | $4M | $5M | $7M | $10M | $12M | $13M | |
| PP&E (Gross) | $48M | $47M | $47M | $46M | $45M | $48M | $48M | $47M | $45M | |
| Accum. Depreciation | $44M | $44M | $43M | $42M | $40M | $41M | $38M | $35M | $32M | |
| Intangibles | $0 | $0 | $1M | $1M | $51.0K | $102.0K | $153.0K | $204.0K | $254.0K | |
| Other Non-current Assets | $3M | $4M | $5M | $6M | $7M | $8M | $286.0K | $239.0K | $1M | |
| Total Assets | $160M | $101M | $57M | $57M | $62M | $63M | $78M | $87M | $43M | |
| Accounts Payable | $30M | $10M | $9M | $10M | $8M | $7M | $12M | $20M | $10M | |
| Accrued Liabilities | $5M | $6M | $6M | $8M | $9M | $9M | $5M | $7M | $4M | |
| Current Liabilities | $48M | $19M | $18M | $40M | $22M | $21M | $19M | $33M | $15M | |
| Capital Leases | $4M | $5M | $5M | $5M | $2M | $3M | $0 | · | · | |
| Other Non-current Liabilities | $7M | $2M | $2M | $2M | $2M | $2M | $1M | · | · | |
| Total Liabilities | $194M | $162M | $164M | $176M | $144M | $111M | $85M | $77M | $70M | |
| Long-term Debt | $45M | $45M | $45M | · | · | $52M | $70M | · | · | |
| Common Stock | $122.0K | $91.0K | $69.0K | $55.0K | $41.0K | $35.0K | $34.0K | $25.0K | $0 | |
| Paid-in Capital | $413M | $303M | $213M | $193M | $175M | $138M | $124M | $71M | $0 | |
| Retained Earnings | $-447M | $-363M | $-319M | $-311M | $-257M | $-186M | $-130M | $-61M | $-120M | |
| Stockholders' Equity | $-34M | $-60M | $-106M | $-119M | $-82M | $-48M | $-6M | $10M | $-26M | |
| Liabilities + Equity | $160M | $101M | $57M | $57M | $62M | $63M | $78M | $87M | $43M | |
| Shares Outstanding | 122,044,299 | 91,413,742 | 68,533,085 | 54,827,734 | 41,228,736 | 34,569,254 | 33,562,885 | 24,957,309 | · |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $548.0K | $718.0K | $1M | $2M | $3M | $3M | $3M | $3M | $4M | |
| Stock-based Comp | $8M | $7M | $3M | $4M | $7M | $7M | $7M | $30M | $0 | |
| Deferred Tax | $0 | $0 | $0 | $0 | · | · | · | · | · | |
| Amort. of Intangibles | $0 | $78.0K | $157.0K | $116.0K | $51.0K | $51.0K | $50.0K | $50.0K | $51.0K | |
| Other Non-cash | · | · | · | · | · | · | · | $15M | · | |
| Operating Cash Flow | $-52M | $-36M | $-6M | $-10M | $-33M | $-45M | $-60M | $-13M | $6M | |
| CapEx | $562.0K | $159.0K | $995.0K | $1M | $913.0K | $517.0K | $663.0K | $2M | $2M | |
| Investing Cash Flow | $-562.0K | $-159.0K | $-995.0K | $-3M | $-913.0K | $-517.0K | $-663.0K | $-2M | $-2M | |
| Financing Cash Flow | $103M | $84M | $4M | $12M | $30M | $28M | $50M | $58M | $4M | |
| Net Change in Cash | $50M | $48M | $-3M | $-751.0K | $-4M | $-18M | · | $43M | $8M | |
| Taxes Paid | $0 | $305.0K | $0 | · | · | · | · | · | · | |
| Free Cash Flow | $-53M | $-36M | $-7M | $-11M | $-34M | $-46M | $-61M | $-15M | · | |
| Levered FCF | · | · | $-14M | $-17M | $-44M | $-57M | $-70M | $-23M | · |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -159.5% | -53.5% | -29.9% | -88.2% | -68.2% | -93.5% | -100.1% | -72.6% | · | |
| Net Margin | -188.1% | -76.7% | -15.6% | -114.1% | -138.8% | -121.7% | -125.9% | -91.0% | · | |
| Pretax Margin | -188.1% | -76.7% | -15.1% | -114.1% | -138.8% | -121.7% | -125.9% | -91.0% | · | |
| EBITDA Margin | -159.5% | -53.5% | -29.9% | -88.2% | -68.2% | -93.5% | -100.1% | -67.8% | · | |
| ROA | -64.0% | -55.6% | -13.8% | -91.4% | -113.0% | -78.9% | -80.1% | -94.5% | · | |
| ROE | 157.7% | 83.6% | 7.5% | 48.1% | 99.0% | 131.2% | 326.5% | -366.2% | · | |
| ROIC | 211.1% | 51.1% | 14.6% | 35.5% | 42.2% | 88.4% | 860.3% | -485.5% | · |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.1 | 4.7 | 2.2 | 1.0 | 2.2 | 2.1 | 3.7 | 2.3 | · | |
| Quick Ratio | 0.4 | 0.4 | · | · | · | 1.5 | 2.7 | 1.8 | · | |
| Interest Coverage | · | · | -2.4 | -6.4 | -3.5 | -3.9 | -5.7 | -6.3 | · |
效率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.7 | 0.9 | 0.8 | 0.8 | 0.6 | 0.6 | 1.0 | · | |
| Inventory Turnover | 3.0 | 2.8 | 3.3 | · | · | 4.9 | · | · | · | |
| Receivables Turnover | 3.5 | 7.3 | · | · | · | · | · | · | · |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-0.28 | $-0.66 | $-1.55 | $-2.16 | $-1.99 | $-1.40 | $-0.18 | $0.40 | · | |
| Revenue / Share | $0.42 | $0.66 | $0.83 | $0.98 | $1.33 | · | · | · | · | |
| Cash Flow / Share | $-0.49 | $-0.41 | $-0.10 | $-0.20 | $-0.87 | · | · | · | · | |
| Cash / Share | · | · | · | · | · | $0.92 | $1.47 | $2.43 | · | |
| EPS (TTM) | $-0.78 | $-0.51 | $-0.13 | $-1.12 | $-1.85 | $-1.66 | · | · | · |
增长率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -22.6% | 13.8% | 6.1% | -6.2% | 10.9% | · | · | · | · | |
| Revenue CAGR 3Y | -2.2% | 4.2% | 3.3% | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -0.58% | · | · | · | · | · | · | · | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $45M | $58M | $51M | $48M | $51M | $46M | $53M | $67M | · | |
| Net Income TTM | $-84M | $-44M | $-8M | $-54M | $-71M | $-56M | $-66M | $-61M | · | |
| Market Cap | $788M | $325M | $138M | $49M | $160M | $185M | $195M | $157M | · | |
| P/E | -8.3 | -7.0 | -15.5 | -0.8 | -2.1 | -3.2 | · | · | · | |
| P/S | 17.7 | 5.7 | 2.7 | 1.0 | 3.2 | 4.0 | 3.7 | 2.3 | · | |
| P/B | -23.4 | -5.4 | -1.3 | -0.4 | -2.0 | -3.8 | -31.9 | 15.6 | · | |
| P / Cash Flow | -15.0 | -9.1 | -21.7 | -5.1 | -4.9 | -4.1 | -3.2 | -12.1 | · | |
| P / FCF | -14.9 | -9.1 | -18.8 | -4.6 | -4.7 | -4.0 | -3.2 | -10.6 | · | |
| Earnings Yield | -12.1% | -14.3% | -6.4% | -124.2% | -47.6% | -31.0% | · | · | · |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $14M | $14M | $13M | $13M | $10M | $9M | $12M | $14M | $20M | $12M | $13M | $13M | $13M | $11M | $11M | $11M | |
| Cost of Revenue | $4M | $3M | $6M | $5M | $5M | $4M | $5M | $4M | $5M | $4M | $5M | $5M | $7M | $5M | $5M | $5M | |
| R&D Expense | $4M | $4M | $3M | $5M | $4M | $5M | $5M | $5M | $4M | $6M | $3M | $3M | $3M | $4M | $4M | $3M | |
| SG&A Expense | $14M | $11M | $33M | $15M | $13M | $19M | $16M | $12M | $11M | $11M | $10M | $7M | $7M | $7M | $12M | $12M | |
| Operating Expenses | $22M | $19M | $42M | $24M | $21M | $28M | $25M | $22M | $20M | $21M | $17M | $15M | $17M | $16M | $21M | $20M | |
| Operating Income | $-8M | $-4M | $-29M | $-11M | $-11M | $-19M | $-14M | $-8M | $55.0K | $-9M | $-4M | $-2M | $-4M | $-5M | $-11M | $-9M | |
| Interest Expense | · | · | · | · | · | · | · | · | $3M | $3M | · | $1M | $1M | $1M | $2M | $2M | |
| Pretax Income | $-23M | $-8M | $-32M | $-15M | $-14M | $-23M | $-17M | $-12M | $-3M | $-13M | $-8M | $-2M | $-6M | $8M | $-12M | $-13M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $-14.0K | $0 | $0 | $0 | $101.0K | $-140.0K | $284.0K | $0 | $0 | $0 | |
| Net Income | $-23M | $-8M | $-32M | $-15M | $-14M | $-23M | $-17M | $-12M | $-3M | $-13M | $-8M | $-2M | $-6M | $8M | $-12M | $-13M | |
| EPS (Basic) | $-0.18 | $-0.07 | $-0.26 | $-0.14 | $-0.14 | $-0.24 | $-0.18 | $-0.13 | $-0.03 | $-0.17 | $-0.15 | $-0.03 | $-0.10 | $0.15 | $-0.21 | $-0.23 | |
| EPS (Diluted) | $-0.18 | $-0.07 | $-0.26 | $-0.14 | $-0.14 | $-0.24 | $-0.18 | $-0.13 | $-0.03 | $-0.17 | $-0.11 | $-0.03 | $-0.10 | $0.11 | $-0.21 | $-0.23 | |
| Shares (Basic) | 124,994,165 | 122,609,995 | · | 110,584,371 | 99,326,701 | 95,497,056 | · | 91,082,081 | 90,911,626 | 73,614,710 | · | 64,678,761 | 57,350,902 | 55,631,947 | · | 53,424,922 | |
| Shares (Diluted) | 124,994,165 | 122,609,995 | · | 110,584,371 | 99,326,701 | 95,497,056 | · | 91,082,081 | 90,911,626 | 73,614,710 | · | 64,678,761 | 57,350,902 | 73,792,886 | · | 53,424,922 | |
| EBITDA | $-8M | $-4M | · | $-11M | $-11M | $-19M | · | $-8M | $55.0K | $-9M | · | $-2M | $-4M | $-5M | · | $-9M |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $98M | $111M | · | $129M | $61M | $69M | · | $78M | $90M | $95M | · | $25M | $22M | $27M | · | $19M | |
| Receivables | $9M | $7M | $18M | · | · | · | $7M | · | · | · | $8M | · | · | · | · | · | |
| Inventory | $7M | $8M | $6M | $8M | $8M | $7M | $6M | $7M | $7M | $8M | $7M | $7M | $6M | $7M | $6M | $7M | |
| Prepaid Expense | $3M | $5M | $4M | $3M | $1M | $3M | $3M | $2M | $1M | $2M | $2M | $2M | $1M | $2M | $2M | $2M | |
| Current Assets | $118M | $130M | $149M | $152M | $82M | $89M | $88M | $97M | $104M | $113M | $41M | $42M | $40M | $44M | $40M | $38M | |
| PP&E (Net) | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $4M | $4M | $4M | |
| PP&E (Gross) | $48M | $48M | $48M | $48M | $48M | $47M | $47M | $47M | $47M | $47M | $47M | $47M | $47M | $46M | $46M | $46M | |
| Accum. Depreciation | $44M | $44M | $44M | $44M | $44M | $44M | $44M | $43M | $43M | $43M | $43M | $43M | $42M | $42M | $42M | $42M | |
| Intangibles | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Other Non-current Assets | $2M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $6M | $6M | $6M | |
| Total Assets | $132M | $141M | $160M | $164M | $94M | $102M | $101M | $110M | $118M | $130M | $57M | $59M | $57M | $61M | $57M | $52M | |
| Accounts Payable | $9M | $12M | $30M | $11M | $12M | $12M | $10M | $8M | $6M | $11M | $9M | $10M | $11M | $12M | $10M | $11M | |
| Accrued Liabilities | $5M | $3M | $5M | $5M | $5M | $3M | $6M | $5M | $6M | $5M | $6M | $5M | $4M | $5M | $8M | $8M | |
| Current Liabilities | $16M | $32M | $48M | $26M | $23M | $18M | $19M | $15M | $14M | $18M | $18M | $24M | $39M | $40M | $40M | $37M | |
| Capital Leases | $8M | $4M | $4M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $6M | $6M | $6M | $5M | $1M | |
| Other Non-current Liabilities | $6M | $6M | $7M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Total Liabilities | $189M | $175M | $194M | $168M | $166M | $163M | $162M | $155M | $153M | $166M | $164M | $162M | $164M | $171M | $176M | $160M | |
| Long-term Debt | $55M | $45M | $45M | $45M | $45M | $45M | · | $45M | $45M | $45M | · | $39M | $39M | $42M | · | $52M | |
| Common Stock | $126.0K | $124.0K | $122.0K | $121.0K | $99.0K | $99.0K | $91.0K | $91.0K | $91.0K | $90.0K | $69.0K | $67.0K | $62.0K | $56.0K | $55.0K | $54.0K | |
| Paid-in Capital | $421M | $421M | $413M | $411M | $327M | $325M | $303M | $301M | $299M | $296M | $213M | $208M | $202M | $194M | $193M | $191M | |
| Retained Earnings | $-478M | $-455M | $-447M | $-415M | $-400M | $-386M | $-363M | $-346M | $-335M | $-332M | $-319M | $-311M | $-309M | $-303M | $-311M | $-299M | |
| Stockholders' Equity | $-57M | $-34M | $-34M | $-4M | $-73M | $-61M | $-60M | $-45M | $-35M | $-36M | $-106M | $-103M | $-107M | $-109M | $-119M | $-108M | |
| Liabilities + Equity | $132M | $141M | $160M | $164M | $94M | $102M | $101M | $110M | $118M | $130M | $57M | $59M | $57M | $61M | $57M | $52M | |
| Shares Outstanding | 125,511,648 | 124,284,542 | 122,044,299 | 121,658,113 | 99,353,270 | 99,317,153 | 91,413,742 | 91,178,193 | 91,059,760 | 90,478,731 | 68,533,085 | 66,740,765 | 61,615,959 | 55,922,361 | 54,827,734 | 53,852,126 |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $136.0K | $113.0K | $130.0K | $139.0K | $140.0K | $139.0K | $147.0K | $159.0K | $205.0K | $207.0K | $467.0K | $264.0K | $289.0K | $325.0K | $397.0K | $596.0K | |
| Stock-based Comp | $3M | $2M | $1M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $940.0K | $774.0K | $631.0K | $344.0K | $714.0K | $535.0K | |
| Amort. of Intangibles | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $39.0K | $39.0K | $40.0K | $39.0K | $39.0K | $39.0K | $51.0K | $39.0K | |
| Operating Cash Flow | $-9M | $-15M | $-8M | $-13M | $-8M | $-23M | $-6M | $-12M | $-7M | $-10M | $-5M | $-2M | $-8M | $9M | $8M | $3M | |
| CapEx | $212.0K | $52.0K | $85.0K | $235.0K | $107.0K | $135.0K | $15.0K | $80.0K | $35.0K | $29.0K | $16.0K | $151.0K | $826.0K | $2.0K | $26.0K | $217.0K | |
| Investing Cash Flow | $-212.0K | $-52.0K | $-85.0K | $-235.0K | $-107.0K | $-135.0K | $-15.0K | $-80.0K | $-35.0K | $-29.0K | $-16.0K | $-151.0K | $-826.0K | $-2.0K | $-26.0K | $-2M | |
| Financing Cash Flow | $-3M | $4M | $660.0K | $81M | $-100.0K | $21M | $157.0K | $-17.0K | $2M | $82M | $4M | $5M | $4M | $-9M | $234.0K | $-138.0K | |
| Net Change in Cash | $-12M | $-10M | $-8M | $69M | $-8M | $-3M | $-6M | $-12M | $-5M | $71M | $-1M | $2M | $-4M | $-391.0K | $9M | $954.0K | |
| Taxes Paid | · | · | $0 | $0 | $-2M | $2M | $0 | $0 | $-698.0K | $1M | $0 | $0 | · | · | · | · | |
| Free Cash Flow | · | $-15M | · | · | · | $-24M | · | · | · | $-10M | · | · | · | $9M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-13M | · | · | · | $7M | · | · |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -59.5% | -29.1% | · | -89.6% | -113.7% | -222.1% | · | -61.2% | 0.27% | -74.3% | · | -18.3% | -31.8% | -41.4% | · | -77.2% | |
| Net Margin | -165.5% | -55.8% | · | -120.6% | -135.4% | -263.0% | · | -85.0% | -13.7% | -106.4% | · | -15.7% | -43.7% | 72.5% | · | -109.4% | |
| Pretax Margin | -165.5% | -55.8% | · | -120.6% | -135.4% | -263.0% | · | -85.0% | -13.7% | -106.4% | · | -16.7% | -41.6% | 72.5% | · | -109.4% | |
| EBITDA Margin | -59.5% | -29.1% | · | -89.6% | -113.7% | -222.1% | · | -61.2% | 0.27% | -74.3% | · | -18.3% | -31.8% | -41.4% | · | -77.2% | |
| ROA | -20.2% | -6.6% | · | -11.3% | -12.8% | -19.8% | · | -13.6% | -3.1% | -13.5% | · | -3.7% | -10.2% | 13.7% | · | -21.4% | |
| ROE | 35.4% | 17.0% | · | 62.4% | 25.1% | 47.2% | · | 15.5% | 3.9% | 17.6% | · | 1.9% | 5.7% | -8.0% | · | 14.9% | |
| ROIC | 14.5% | 12.3% | · | 279.4% | 15.7% | 31.8% | · | 18.2% | -0.16% | 24.7% | · | 2.2% | 4.2% | 4.2% | · | 8.2% |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.2 | 4.1 | · | 5.9 | 3.5 | 4.9 | · | 6.4 | 7.5 | 6.3 | · | 1.8 | 1.0 | 1.1 | · | 1.0 | |
| Quick Ratio | 6.5 | 3.7 | · | 5.0 | 2.6 | 3.8 | · | 5.1 | 6.5 | 5.3 | · | 1.0 | 0.6 | 0.7 | · | 0.5 | |
| Interest Coverage | · | · | · | · | · | · | · | · | 0.0 | -3.2 | · | -1.9 | -3.1 | -3.2 | · | -5.4 |
效率
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.2 | 0.2 | 0.1 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Inventory Turnover | 0.5 | 0.5 | · | 0.6 | 0.6 | 0.5 | · | 0.6 | 0.7 | 0.6 | · | 0.7 | 1.2 | 0.8 | · | 1.0 | |
| Receivables Turnover | 1.7 | 4.2 | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-0.45 | $-0.27 | · | $-0.03 | $-0.73 | $-0.61 | · | $-0.50 | $-0.39 | $-0.40 | · | $-1.54 | $-1.73 | $-1.95 | · | $-2.00 | |
| Revenue / Share | $0.11 | $0.12 | · | $0.12 | $0.10 | $0.09 | · | $0.15 | $0.22 | $0.16 | · | $0.20 | $0.23 | $0.15 | · | $0.21 | |
| Cash Flow / Share | · | $-0.12 | · | · | · | $-0.24 | · | · | · | $-0.14 | · | · | · | $0.12 | · | · | |
| Cash / Share | $0.78 | $0.89 | · | $1.06 | $0.61 | $0.69 | · | $0.85 | $0.99 | $1.05 | · | $0.37 | $0.36 | $0.48 | · | $0.35 | |
| EPS (TTM) | $-0.65 | $-0.61 | · | $-0.70 | $-0.69 | $-0.58 | · | $-0.44 | $-0.34 | $-0.41 | · | $-0.23 | $-0.43 | $-0.69 | · | $-1.65 |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $54M | $50M | · | $43M | $44M | $54M | · | $59M | $58M | $52M | · | $48M | $47M | $47M | · | $48M | |
| Net Income TTM | $-78M | $-69M | · | $-69M | $-65M | $-54M | · | $-35M | $-26M | $-29M | · | $-12M | $-23M | $-33M | · | $-71M | |
| Market Cap | $522M | $516M | · | $680M | $329M | $288M | · | $454M | $237M | $385M | · | $102M | $102M | $64M | · | $63M | |
| P/E | -6.4 | -6.8 | · | -8.0 | -4.8 | -5.0 | · | -11.3 | -7.6 | -10.4 | · | -6.7 | -3.8 | -1.7 | · | -0.7 | |
| P/S | 9.7 | 10.3 | · | 15.7 | 7.5 | 5.3 | · | 7.7 | 4.1 | 7.5 | · | 2.1 | 2.2 | 1.4 | · | 1.3 | |
| P/B | -9.2 | -15.1 | · | -165.5 | -4.5 | -4.7 | · | -10.0 | -6.7 | -10.6 | · | -1.0 | -1.0 | -0.6 | · | -0.6 | |
| P / Cash Flow | · | -34.8 | · | · | · | -12.3 | · | · | · | -37.1 | · | · | · | 7.2 | · | · | |
| Earnings Yield | -15.6% | -14.7% | · | -12.5% | -20.8% | -20.0% | · | -8.8% | -13.1% | -9.6% | · | -15.0% | -26.1% | -60.5% | · | -141.0% |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 收入 | $45M | $58M | $51M | $48M | $51M |
| 营业利润率 % | -159.5% | -53.5% | -29.9% | -88.2% | -68.2% |
| 净收入 | $-84M | $-44M | $-8M | $-54M | $-71M |
| 稀释后每股收益 (EPS) | $-0.78 | $-0.51 | $-0.13 | $-1.12 | $-1.85 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 流动比率 | 3.1 | 4.7 | 2.2 | 1.0 | 2.2 |
| 速动比率 | 0.4 | 0.4 | · | · | · |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | $-53M | $-36M | $-7M | $-11M | $-34M |
机构持有人 (13F) 196 家申报者 · $337.8M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
持有人
196
持有价值
$337.8M
新仓位
26
已退出持仓
18
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 26 (-23 与上一季度对比) | 18 (-29 与上一季度对比) | 68 (+9 与上一季度对比) | 49 (0 与上一季度对比) | -1.2M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| Bratton Capital Management, L.P. | $40813585 | 9810958 | 12.08% | 股份 |
| VANGUARD GROUP INC | $38064478 | 5892334 | 11.27% | 股份 |
| BlackRock, Inc. | $33568590 | 8069373 | 9.94% | 股份 |
| RTW INVESTMENTS, LP | $30894119 | 7426471 | 9.15% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $19071657 | 4584533 | 5.65% | 股份 |
| FEDERATED HERMES, INC. | $12948253 | 3112561 | 3.83% | 股份 |
| STATE STREET CORP | $12180563 | 2928020 | 3.61% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $10913743 | 2622888 | 3.23% | 股份 |
| SAMSARA BIOCAPITAL, LLC | $10400000 | 2500000 | 3.08% | 股份 |
| BANK OF AMERICA CORP /DE/ | $6940640 | 1668423 | 2.05% | 股份 |
| Sio Capital Management, LLC | $6182488 | 1486175 | 1.83% | 股份 |
| Propel Bio Management, LLC | $6000372 | 1442397 | 1.78% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $5329904 | 1281227 | 1.58% | 股份 |
| Nuveen, LLC | $5055336 | 1215225 | 1.50% | 股份 |
| WELLS FARGO & COMPANY/MN | $4530394 | 1089037 | 1.34% | 股份 |
| COMMONWEALTH EQUITY SERVICES, LLC | $4352090 | 1046175 | 1.29% | 股份 |
| BARCLAYS PLC | $4146126 | 996665 | 1.23% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3951168 | 949800 | 1.17% | 买入期权 |
| Blue Owl Capital Holdings LP | $3922597 | 942932 | 1.16% | 股份 |
| WASATCH ADVISORS LP | $3645011 | 878316 | 1.08% | 股份 |
| NORTHERN TRUST CORP | $3457589 | 831151 | 1.02% | 股份 |
| BNP PARIBAS FINANCIAL MARKETS | $3305902 | 794688 | 0.98% | 股份 |
| Balyasny Asset Management L.P. | $3097270 | 744536 | 0.92% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $3054459 | 734245 | 0.90% | 股份 |
| MORGAN STANLEY | $2739848 | 658617 | 0.81% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $2709038 | 651211 | 0.80% | 股份 |
| DAFNA Capital Management LLC | $2687006 | 645915 | 0.80% | 股份 |
| Everstar Asset Management, LLC | $2545683 | 611943 | 0.75% | 股份 |
| TWO SIGMA ADVISERS, LP | $2147304 | 332400 | 0.64% | 股份 |
| AWM Investment Company, Inc. | $1977664 | 475400 | 0.59% | 股份 |
| GOLDMAN SACHS GROUP INC | $1949247 | 468569 | 0.58% | 股份 |
| Bracebridge Capital, LLC | $1910339 | 459216 | 0.57% | 股份 |
| UBS Group AG | $1907002 | 458414 | 0.56% | 股份 |
| CITADEL ADVISORS LLC | $1881140 | 452197 | 0.56% | 股份 |
| JANE STREET GROUP, LLC | $1819958 | 437490 | 0.54% | 股份 |
| RENAISSANCE TECHNOLOGIES LLC | $1731592 | 416248 | 0.51% | 股份 |
| STIFEL FINANCIAL CORP | $1505516 | 361903 | 0.45% | 股份 |
| Man Group plc | $1463072 | 351700 | 0.43% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1286272 | 309200 | 0.38% | 卖出期权 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1274599 | 306394 | 0.38% | 股份 |
| WELLINGTON MANAGEMENT GROUP LLP | $1254852 | 301647 | 0.37% | 股份 |
| MARSHALL WACE, LLP | $1188340 | 285659 | 0.35% | 股份 |
| Walleye Capital LLC | $1175483 | 282568 | 0.35% | 股份 |
| Simplify Asset Management Inc. | $1159488 | 278723 | 0.34% | 股份 |
| Bank of New York Mellon Corp | $1146264 | 275544 | 0.34% | 股份 |
| Russell Investments Group, Ltd. | $1083599 | 260481 | 0.32% | 股份 |
| Rosalind Advisors, Inc. | $1040000 | 250000 | 0.31% | 股份 |
| Latash Investments, LLC | $1011437 | 243134 | 0.30% | 股份 |
| Hudson Bay Capital Management LP | $973440 | 234000 | 0.29% | 股份 |
| Lido Advisors, LLC | $895715 | 215316 | 0.27% | 股份 |
公司内部人士 29 位内幕人士 · 19 位高管 · 11 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Daniel Barber | President and CEO | 2026年9月15日 S | 652317 | 0 | 7 | $-1220735 |
| Keith J Kendall | CEO and President | 2022年3月10日 A | 1000 | 0 | 0 | $0 |
| Ernest A Toth JR | Chief Financial Officer | 2026年5月5日 F | 283460 | 0 | 1 | $-242919 |
| John T. Maxwell | SVP-Chief Financial Officer | 2020年8月18日 S | 150614 | 0 | 0 | $0 |
| Cassie Jung | Chief Operating Officer | 2026年9月3日 X | 206833 | 0 | 2 | $-664649 |
| Sherry Korczynski | Chief Commercial Officer | 2026年9月9日 M | 235689 | 0 | 2 | $-111315 |
| Peter E. Boyd | Chief People Officer | 2026年9月9日 X | 284024 | 0 | 2 | $-194324 |
| Thomas A. Zalewski | Chief Legal Officer | 2026年5月18日 A | 100000 | 0 | 0 | $0 |
| Melina Cioffi | SVP, Regulatory Affairs | 2026年5月15日 F | 273200 | 0 | 1 | $-105547 |
| Lori J Braender | Corporate Secretary | 2026年5月7日 F | 231042 | 0 | 1 | $-167225 |
| Matthew J. Greenhawt | Chief Medical Officer | 2026年3月9日 A | 75000 | 0 | 0 | $0 |
| Matthew W. Davis | Chief Development Officer | 2026年3月9日 A | 100000 | 0 | 0 | $0 |
| Carl N Kraus | Chief Medical Officer | 2025年10月15日 S | 282475 | 0 | 1 | $-141904 |
| Stephen Wargacki | Chief Science Officer | 2025年3月7日 A | 343552 | 0 | 0 | $0 |
| Alexander Mark Schobel | Chief Innovation/Tech Officer | 2024年3月9日 F | 980726 | 0 | 0 | $0 |
| Ken W. Marshall | SVP, Chief Commercial Officer | 2023年8月9日 A | 150000 | 0 | 0 | $0 |
| Kenneth Truitt | Chief Medical Officer | 2022年9月6日 A | · | 0 | 0 | $0 |
| Theresa Wood | SVP-HR and Org. Development | 2022年3月10日 A | 80765 | 0 | 0 | $0 |
| Gary H Slatko | SVP, Chief Medical Officer | 2020年3月16日 A | · | 0 | 0 | $0 |
| Julie Krop | 董事 | 2026年6月23日 M | 0 | 0 | 1 | $-125500 |
| Abigail L. Jenkins | 董事 | 2026年6月10日 A | · | 0 | 0 | $0 |
| Marco Taglietti | 董事 | 2026年6月10日 A | · | 0 | 0 | $0 |
| John Cochran | 董事 | 2026年6月10日 A | 99486 | 0 | 0 | $0 |
| Gregory B Brown | 董事 | 2026年6月10日 A | · | 0 | 0 | $0 |
| Timothy E Morris | 董事 | 2026年6月10日 A | · | 0 | 0 | $0 |
| COSTA SANTO J | 董事 | 2024年6月20日 A | · | 0 | 0 | $0 |
| Nancy Lurker | 董事 | 2021年6月15日 A | · | 0 | 0 | $0 |
| James S Scibetta | 董事 | 2021年6月15日 A | 31635 | 0 | 0 | $0 |
| Douglas K Bratton | 10% 所有者 | 2024年12月2日 G | 199841 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 16 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| PILL · Direxion Shares ETF Trust | 0.51% | 28299 NS | 2026年7月31日 | N-PORT |
| QQQS · Invesco Exchange-Traded Fund Trus... | 0.45% | 23471 SH | 2026年10月2日 | 每日 |
| IWC · iShares Trust | 0.13% | 367240 SH | 2026年9月11日 | 每日 |
| IBBQ · Invesco Exchange-Traded Fund Trus... | 0.04% | 8980 SH | 2026年10月2日 | 每日 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.02% | 59348 SH | 2026年8月19日 | 每日 |
| IWM · iShares Trust | 0.02% | 2767037 SH | 2026年9月11日 | 每日 |
| IWO · iShares Trust | 0.01% | 374338 SH | 2026年9月11日 | 每日 |
| RSSL · Global X Funds | 0.01% | 51582 NS | 2026年7月31日 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 621390 SH | 2026年8月19日 | 每日 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.01% | 43284 SH | 2026年8月19日 | 每日 |
| ITOT · iShares Trust | 0.00% | 165523 SH | 2026年9月11日 | 每日 |
| IWV · iShares Trust | 0.00% | 34314 SH | 2026年9月11日 | 每日 |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 1077349 SH | 2026年8月19日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 3403709 SH | 2026年8月19日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 10223 SH | 2026年8月19日 | 每日 |
| IWN · iShares Trust | · | 638760 SH | 2026年9月11日 | 每日 |
AQST 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
评级 · 15 位分析师
买入
中位数目标
$10.00
+119.8%
4 26.7%
强烈买入
10 66.7%
买入
1 6.7%
持有
0 0.0%
卖出
0 0.0%
强烈卖出
12个月价格目标
9 位分析师 · 2026-10-04平均目标 $9.33 +105.1%
← 低于所有目标
当前价格 $4.55
最低$6.00
平均值$9.33
最高$11.00
同行比较（GICS 子行业） 关键指标与行业同行对比
财年依据，价格截至各公司上一个财年末收盘价。
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| AQST | $788M | -8.3 | -22.6% | -188.1% | 157.7% | · |
| COLL | $1.47B | 26.8 | 23.6% | 8.1% | 23.5% | 59.4% |
| ACRS | $363M | -5.7 | -58.2% | -829.6% | -55.3% | · |
| CRMD | $922M | 5.7 | 617.0% | 52.3% | 52.1% | 88.5% |
| ZVRA | $509M | 6.6 | 350.9% | 78.2% | 61.2% | · |
| PHAT | $1.18B | -5.5 | 216.9% | -126.4% | 52.4% | 87.1% |
| EOLS | $432M | -8.3 | 11.6% | -17.4% | 247.3% | 66.3% |
| CTNM | · | -5.3 | · | · | -27.7% | · |
| ARVN | $753M | -10.4 | -0.30% | -30.8% | -15.5% | · |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。
来源：SEC 10-Q 于 八月 11, 2026 申报